4//SEC Filing
Biondi Paul 4
Accession 0000899243-20-009250
CIK 0001609809other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:11 PM ET
Size
5.4 KB
Accession
0000899243-20-009250
Insider Transaction Report
Form 4
Biondi Paul
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-03-20+30,000→ 30,000 totalExercise: $3.10Exp: 2030-03-19→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest in four equal installments on each anniversary of March 20, 2020 or in full immediately prior to the occurrence of a change in control.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001744508
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 4:11 PM ET
- Size
- 5.4 KB